{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9068012",
  "DateCompleted": {
    "Year": "1997",
    "Month": "05",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "02",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1015-2008",
      "JournalIssue": {
        "Volume": "64",
        "Issue": "5",
        "PubDate": {
          "Year": "1996"
        }
      },
      "Title": "Pathobiology : journal of immunopathology, molecular and cellular biology",
      "ISOAbbreviation": "Pathobiology"
    },
    "ArticleTitle": "Muramyl-dipeptide-induced fever in cats.",
    "Pagination": {
      "StartPage": "279",
      "EndPage": "283",
      "MedlinePgn": "279-83"
    },
    "Abstract": {
      "AbstractText": [
        "The characteristics of fever induced by intravenous injection of muramyl dipeptide (MDP; 25 micrograms/kg) were studied in cats implanted with electrodes for chronic recording of electromyograms, brain temperature (Tb) and subcutaneous temperature. Intravenous injection of MDP was followed by a bimodal fever response after a latent period of 19.4 +/- 1.3 min. Maximum Tb was reached 62.0 +/- 20.7 min after injection, with a second minor peak at about 4 h following injection. Tb returned to baseline after 6-8 h. A single intravenous injection of MDP induced a stable reproducible thermal response which allowed to study the properties of body temperature and effector mechanisms during fever in cats."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biology, Worchester State College, MA 01602, USA."
          }
        ],
        "LastName": "Amini-Sereshki-Kormi",
        "ForeName": "L",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "GrantID": "NS 20794",
        "Acronym": "NS",
        "Agency": "NINDS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Pathobiology",
    "NlmUniqueID": "9007504",
    "ISSNLinking": "1015-2008"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "53678-77-6",
      "NameOfSubstance": "Acetylmuramyl-Alanyl-Isoglutamine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "toxicity"
      ],
      "DescriptorName": "Acetylmuramyl-Alanyl-Isoglutamine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Behavior, Animal"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Body Temperature"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cats"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Electroencephalography"
    },
    {
      "QualifierName": [
        "chemically induced",
        "physiopathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Injections, Intravenous"
    }
  ]
}